Invention Grant
- Patent Title: HIV protease inhibitors
-
Application No.: US16849747Application Date: 2020-04-15
-
Publication No.: US11318119B2Publication Date: 2022-05-03
- Inventor: Aesop Cho , John O. Link , Jie Xu
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/52 ; A61K31/537 ; A61K31/675 ; A61K45/06 ; A61P31/18 ; A61K31/7076 ; C07D403/10 ; C07D403/14

Abstract:
The present disclosure provides compounds, or a pharmaceutically acceptable salt thereof as described herein, useful for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a subject. The disclosure also provides pharmaceutical compositions comprising these compounds, processes for preparing them, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a subject using these compounds. The present disclosure also provides compounds, or a pharmaceutically acceptable salt thereof as described herein, useful for treating the proliferation of a coronavirus, treating coronavirus symptoms or delaying the onset of coronavirus symptoms in a subject. The disclosure also provides pharmaceutical compositions comprising these compounds, processes for preparing them, therapeutic methods for treating the proliferation of a coronavirus, treating coronavirus symptoms or delaying the onset of coronavirus symptoms in a subject using these compounds.
Public/Granted literature
- US20200345699A1 HIV PROTEASE INHIBITORS Public/Granted day:2020-11-05
Information query